Literature DB >> 21767174

Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.

Per Munck Af Rosenschöld1, Silke Engelholm, Lars Ohlhues, Ian Law, Ivan Vogelius, Svend Aage Engelholm.   

Abstract

PURPOSE: The purpose of this study was to compare treatment plans generated using fixed beam Intensity Modulated photon Radiation Therapy (IMRT), inversely optimized arc therapy (RapidArc(R), RA) with spot-scanned Intensity Modulated Proton Therapy (IMPT) for high-grade glioma patients. Plans were compared with respect to target coverage and sparing of organs at risk (OARs), with special attention to the possibility of hippocampus sparing.
METHOD: Fifteen consecutive patients diagnosed with grade III and IV glioma were selected for this study. The target and OARs were delineated based on computed tomography (CT), FDG-positron emission tomography (PET) and T1-, T2-weigted, and Diffusion Tensor Imaging (DTI) magnetic resonance imaging (MRI) and fiber-tracking. In this study, a 6 MV photon beam on a linear accelerator with a multileaf collimator (MLC) with 2.5 mm leaves and a spot-scanning proton therapy machine were used. Two RA fields, using both a coplanar (clinical standard) and a non-coplanar, setup was compared to the IMRT and IMPT techniques. Three and three to four non-coplanar fields where used in the spot-scanned IMPT and IMRT plans, respectively. The same set of planning dose-volume optimizer objective values were used for the four techniques. The highest planning priority was given to the brainstem (maximum 54 Gy) followed by the PTV (prescription 60 Gy); the hippocampi, eyes, inner ears, brain and chiasm were given lower priority. Doses were recorded for the plans to targets and OARs and compared to our clinical standard technique using the Wilcoxon signed rank test. RESULT: The PTV coverage was significantly more conform for IMPT than the coplanar RA technique, while RA plans tended to be more conform than the IMRT plans, as measured by the standard deviation of the PTV dose. In the cases where the tumor was confined in one cerebral hemisphere (eight patients), the non-coplanar RA and IMPT techniques yielded borderline significantly lower doses to the contralateral hippocampus compared to the standard (22% and 97% average reduction for non-coplanar RA and IMPT, respectively). The IMPT technique allowed for the largest healthy tissue sparing of the techniques in terms of whole brain doses and to the fiber tracts. The maximum doses to the chiasm and brainstem were comparable for all techniques.
CONCLUSION: The IMPT technique produced the most conform plans. For tumors located in the one of the cerebral hemispheres, the non-coplanar RA and the IMPT techniques were able to reduce doses to the contralateral hippocampus. The IMPT technique offered the largest sparing of the brain and fiber tracts. RA techniques tended to produce more conform target doses than IMRT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767174     DOI: 10.3109/0284186X.2011.584555

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.

Authors:  Per Munck Af Rosenschold; Junia Costa; Svend Aage Engelholm; Michael J Lundemann; Ian Law; Lars Ohlhues; Silke Engelholm
Journal:  Neuro Oncol       Date:  2014-12-23       Impact factor: 12.300

Review 2.  [Cognitive deficits following brain tumor radiation therapy].

Authors:  M Buthut; R Haussmann; A Seidlitz; M Krause; M Donix
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

3.  A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning.

Authors:  Mikael Agn; Per Munck Af Rosenschöld; Oula Puonti; Michael J Lundemann; Laura Mancini; Anastasia Papadaki; Steffi Thust; John Ashburner; Ian Law; Koen Van Leemput
Journal:  Med Image Anal       Date:  2019-03-22       Impact factor: 8.545

4.  Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.

Authors:  Michael Lundemann; Per Munck Af Rosenschöld; Aida Muhic; Vibeke A Larsen; Hans S Poulsen; Svend-Aage Engelholm; Flemming L Andersen; Andreas Kjær; Henrik B W Larsson; Ian Law; Adam E Hansen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-02       Impact factor: 9.236

5.  Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe.

Authors:  Jun Yuan; Mingjun Lei; Zhen Yang; Jun Fu; Lei Huo; Jidong Hong
Journal:  Mol Clin Oncol       Date:  2016-04-22

6.  Children's Oncology Group L991 final study report: Establishing an important benchmark for assessing late effects of trimodality care of pediatric patients treated for high grade gliomas.

Authors:  Ralph Ermoian; Matthew Ladra; Shilpen Patel
Journal:  Transl Pediatr       Date:  2012-07

Review 7.  [Target volume concepts in radiotherapy and their implications for imaging].

Authors:  N G Burnet; D J Noble; A Paul; G A Whitfield; S Delorme
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

Review 8.  Functional imaging in adult and paediatric brain tumours.

Authors:  Andrew C Peet; Theodoros N Arvanitis; Martin O Leach; Adam D Waldman
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

9.  A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

Authors:  Paul D Brown; Caroline Chung; Diane D Liu; Sarah McAvoy; David Grosshans; Karine Al Feghali; Anita Mahajan; Jing Li; Susan L McGovern; Mary-Fran McAleer; Amol J Ghia; Erik P Sulman; Marta Penas-Prado; John F de Groot; Amy B Heimberger; Jihong Wang; Terri S Armstrong; Mark R Gilbert; Nandita Guha-Thakurta; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300

10.  Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.

Authors:  Michael C Jin; Siyu Shi; Adela Wu; Navjot Sandhu; Michael Xiang; Scott G Soltys; Susan Hiniker; Gordon Li; Erqi L Pollom
Journal:  Neurooncol Pract       Date:  2020-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.